日本三级韩国三级香港三级A级

    1. <td id="ifbvw"><strike id="ifbvw"></strike></td>
      <p id="ifbvw"><strong id="ifbvw"><xmp id="ifbvw"></xmp></strong></p>
        • 021-20985259

        洛啟生物產品管線

        Project Target Indicatioin Immunization Library Construction Functional identification Humanization Efficacy study Cell line Process Development GMP manufacturing TOX study IND
        LQ001 CD47 Lymphoma,Non-Hodgkin;Ovarian Cancer
        LQ002 PD-L1 Non-Small Cell Lung Cancer;Breast Cancer
        LQ008 PD-1 Non-Small Cell Lung Cancer;Breast Cancer
        LQ004 PD-L1/XX Head and Neck Squamous Cell Carcinoma
        LQ005 PD-1/XX LarynxCancer;Head and Neck Squamous CellCarcinoma
        LQ007 CD47/XX Lymphoma,Non-Hodgkin;Ovarian Cancer
        上海洛啟生物醫藥技術有限公司版權所有Shanghai Novamab Biopharmaceuticals Co., Ltd   滬ICP備19011463號-1   滬公網安備 31011502016044號 技術支持:朗企科技
        日本三级韩国三级香港三级A级